ICCC: Immucell Corp. Company Profile & Statistics

About

ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea.

Info & Links

CEO

Michael F. Brigham

Headquarters

56 EVERGREEN DR
PORTLAND, ME 04103, UNITED STATES

Auditor

WIPFLI LLP

Share holders

642

Employees

Immucell Corp. Statistics

Valuation Measures

Market Capitalization²

43.21M

Enterprise Value

50.31M

Enterprise Value/EBITDA(ttm)

-94.05

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.84

Price to Book(mrq)

1.66

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

26.28%

Operating Margin(ttm)

-15.99%

Profit Margin(ttm)

-17.01%

Return on Equity(ttm)

-15.32%

Return on Invested Capital(ttm)

-11.03%

Return on Assets(ttm)

-8.81%

Income Statement

Revenue(ttm)

23.84M

Revenue Per Share(ttm)

2.67

Gross Profit(ttm)

6.37M

EBITDA(ttm)³

-534.90K

Net Income Available to Common(ttm)

-3.81M

Diluted EPS(ttm)

-0.50

Share Statistics

Beta (5Y Monthly)

0.60

52-Week Change

7.11%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

8.91M

Dividend Yield

0.00%

Float⁴

8.32M

% Held by Insiders

6.60%

% Held by Institutions

13.47%

Balance Sheet

Total Cash(mrq)

3.81M

Total Cash Per Share(mrq)

0.43

Total Debt(mrq)

10.90M

Total Debt/Equity(mrq)

41.28%

Current Ratio(mrq)

3.11%

Quick Ratio(mrq)

1.44%

Book Value Per Share(mrq)

2.99

Cash Flow

Operating Cash Flow Per Share(ytd)

0.04

Free Cash Flow(ytd)

95.90K

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ICCC

Immucell Corp.

Immucell Corp. Profile